ATHE Neutral Sentiment
ASX ANNOUNCEMENT 8 January 2024 Notice Under Section 708A(5)(e) of the Corporations Act This notice is given by Alterity Therapeutics Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), under
Monday, January 8, 2024 BiopharmaWatch Research 1 min read Key Takeaway: Alterity Therapeutics Limited has issued a notice under Section 708A(5)(e) of the Corporations Act regarding the issuance of fully paid ordinary shares. On 8 January 2024, the company issued a total of 1,008,965,805 shares. This notice is a routine compliance declaration as part of corporate governance requirements. The company is trading under the ASX code ATH and NASDAQ ticker ATHE. Details regarding the issuance were provided, but no specific business developments or impacts were discussed.
Full Press Release Details
Notice Under Section 708A(5)(e) of the Corporations
This notice is given by Alterity Therapeutics
Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), under section 708A(5)(e) of the
Corporations Act 2001 (Cth) (Corporations Act).
Details of securities issued
| Type | | Shares |
| Class/Description | | Fully paid ordinary shares |
| ASX Code | | ATH |
| Date of Issue | | 8 January 2024 |
| Number Issued | | 1,008,965,805 |
The Company gives notice pursuant to
section 708A(5)(e) of the Corporations Act that:
Alterity Therapeutics Limited ACN 080
Level 3, 62 Lygon Street Carlton Victoria